Key facts
- This page summarizes Gordon Winston Kinder's Form 4 filing for Bluejay Diagnostics, Inc. (BJDX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 Mar 2022, 11:57.
Gordon Winston Kinder - 17 Mar 2022 Form 4 Insider Report for Bluejay Diagnostics, Inc. (BJDX)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- BJDX
- Reported as of
- 17 Mar 2022
- Net transaction value
- +$2,898
- SEC form
- 4
- Accepted by SEC
- 21 Mar 2022, 11:57:08 UTC
- Prior SEC filing
- 16 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gordon Kinder
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Gordon Winston Kinder filed Form 4 for Bluejay Diagnostics, Inc. (BJDX) on 21 Mar 2022.
Change
- Previous filing in this sequence was filed on 16 Mar 2022.
- Current net transaction value: +$2,898.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BJDX
transaction
Common Stock
Purchase
- Transaction value
- $2,898
- Shares
- +2,500
- Change %
- +16%
- Price
- $1.16*
- Shares after
- 18,500
- Date
- 17 Mar 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.